Drug · DIN 02400995
PICATO
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 14, 2020; first marketed March 21, 2013.
- Drug Identification Number (DIN)
- 02400995
- Company (DIN owner)
- Leo Pharma IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Ingenol mebutate D06BX02
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INGENOL MEBUTATE | 0.05 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 30, 2013: NOC 14051New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “picato”. A notice may cover another product or only some lots: read it to see what it covers.
- PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin CancerOctober 27, 2020 · Drugs · Product safety
Other DINs named PICATO
- DIN 02400987 · Cancelled Post Market